KO-947 - Kura Oncology
Menin MLL inhibitors - Kura Oncology
Zarnestra (tipifarnib) - Kura Oncology
http://www.globenewswire.com/news-release/2019/07/25/1887925/0/en/Kura-Oncology-to-Report-Second-Quarter-2019-Financial-Results.html
 
Jul 25, 2019
 
Prev Next